Methods-based proficiency testing in molecular genetic pathology.

This Perspectives article describes methods-based proficiency testing (MBPT), the benefits and limitations of MBPT, why the time is right for MBPT in molecular diagnostics, and how MBPT for next-generation sequencing is being developed by the College of American Pathologists.

[1]  Rosemary C. She,et al.  Verification of performance specifications for a US Food and Drug Administration-approved molecular microbiology test: Clostridium difficile cytotoxin B using the Becton, Dickinson and Company GeneOhm Cdiff assay. , 2012, Archives of pathology & laboratory medicine.

[2]  Iris Schrijver,et al.  Verification of performance specifications of a molecular test: cystic fibrosis carrier testing using the Luminex liquid bead array. , 2012, Archives of pathology & laboratory medicine.

[3]  Barbara Zehnbauer,et al.  Current landscape and new paradigms of proficiency testing and external quality assessment for molecular genetics. , 2013, Archives of pathology & laboratory medicine.

[4]  W. Grody,et al.  ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007 , 2008, Genetics in Medicine.

[5]  Marina N Nikiforova,et al.  Validation of KRAS testing for anti-EGFR therapeutic decisions for patients with metastatic colorectal carcinoma. , 2012, Archives of pathology & laboratory medicine.

[6]  Daynna J Wolff,et al.  Validation of fluorescence in situ hybridization using an analyte-specific reagent for detection of abnormalities involving the mixed lineage leukemia gene. , 2012, Archives of pathology & laboratory medicine.

[7]  Elaine Lyon,et al.  Three-year experience of a CAP/ACMG methods-based external proficiency testing program for laboratories offering DNA sequencing for rare inherited disorders , 2013, Genetics in Medicine.

[8]  P. Ahmad-Nejad,et al.  Methodologic European external quality assurance for DNA sequencing: the EQUALseq program. , 2006, Clinical chemistry.

[9]  Whitney Wooderchak-Donahue,et al.  Design and analytical validation of clinical DNA sequencing assays. , 2012, Archives of pathology & laboratory medicine.

[10]  M. Gulley,et al.  Recommended principles and practices for validating clinical molecular pathology tests. , 2009, Archives of pathology & laboratory medicine.

[11]  Adam Kiezun,et al.  Computational and statistical approaches to analyzing variants identified by exome sequencing , 2011, Genome Biology.

[12]  Andrew Wallace,et al.  A standardized framework for the validation and verification of clinical molecular genetic tests , 2010, European Journal of Human Genetics.

[13]  Soma Das,et al.  Technical Standards and Guidelines: Molecular Genetic Testing for Ultra-Rare Disorders , 2005, Genetics in Medicine.

[14]  Iris Schrijver,et al.  Test verification and validation for molecular diagnostic assays. , 2012, Archives of pathology & laboratory medicine.

[15]  S. Antonarakis,et al.  Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion , 2000 .

[16]  Karl V Voelkerding,et al.  Developing genome and exome sequencing for candidate gene identification in inherited disorders: an integrated technical and bioinformatics approach. , 2013, Archives of pathology & laboratory medicine.

[17]  Suzanne Kamel-Reid,et al.  Design and analytic validation of BCR-ABL1 quantitative reverse transcription polymerase chain reaction assay for monitoring minimal residual disease. , 2012, Archives of pathology & laboratory medicine.

[18]  Frederick A. Smith,et al.  Validation of Multiplex Ligation-Dependent Probe Amplification for Confirmation of Array Comparative Genomic Hybridization , 2011, Diagnostic molecular pathology : the American journal of surgical pathology, part B.